전체 논문 (9편 · 1/1)
-
Dual agonism and selective T-cell depletion activity of a PD-1-directed antibody for treating autoimmune diseases.
-
The making of multispecific immunoglobulins - a clinical perspective.
-
Expanding the horizons of cancer therapy with next-generation 4-1BB agonists: a review of molecular and clinical strategies to maximize efficacy and ensure safety.
-
Discovery and characterization of two anti-PD-1 antibodies with a unique binding mechanism to human PD-1.
-
AbDrop-a scalable microfluidics-enabled platform for rapid discovery and functional analysis of plasma cell-derived antibodies.
-
A bispecific antibody-drug conjugate targeting CD7 and CD33 shows anti-tumor activity and improved tumor selectivity in an aggressive subtype of acute myeloid leukemia.
-
A bispecific antibody-drug conjugate targeting pCAD and CDH17 has antitumor activity and improved tumor-specificity.
-
Preclinical development of ozuriftamab vedotin (BA3021), a novel ROR2-specific conditionally active biologic antibody-drug conjugate.
-
Improving dual targeting selectivity in T-cell engagers via synapse-gated and affinity-tuned trispecific antibody design.